Yan Wisnu Prajoko

ORCID: 0000-0003-2659-9923 · 1 paper in corpus · active 2023

Study types

  • article 1
article 2023
·doi:10.3889/oamjms.2023.10980

BACKGROUND: Aromatase inhibitor therapy is commonly used for breast cancer patients with characteristics of positive estrogen and progesterone receptors test without metastases. Thus, this kind of therapy generally gives side effects of aro…